TDC
QDEL icon

Thompson Davis & Co’s QuidelOrtho QDEL Stock Holding History

Thompson Davis & Co’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-125
Closed -$5K – 702
2017
Q4 		$5K Buy
+125
New +$5.11K 0.01% 524
2017
Q3 		– Sell
-400
Closed -$11K – 1175
2017
Q2 		$11K Buy
+400
New +$9.9K 0.02% 636
2016
Q4 		– Sell
-125
Closed -$3K – 1188
2016
Q3 		$3K Buy
+125
New +$2.67K 0.01% 945
2016
Q1 		– Sell
-125
Closed -$3K – 1146
2015
Q4 		$3K Buy
+125
New +$2.54K ﹤0.01% 950

Other funds holding QDEL

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Thompson Davis & Co's QDEL Position: Q1 2018 in Review

Thompson Davis & Co sold out of QuidelOrtho (QDEL) in Q1 2018, closing a stake of 125 shares — an estimated $5K sold.

Thompson Davis & Co first reported a position in QDEL in Q4 2015 and held it in 4 quarters. The position peaked at $11K in Q2 2017. 148 funds tracked by Wall St. Rank hold QDEL as of Q1 2018.

  • Thompson Davis & Co reported no remaining QuidelOrtho position as of Q1 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 125 QuidelOrtho shares in Q1 2018, an estimated $5K.
  • Thompson Davis & Co first reported a position in QuidelOrtho in Q4 2015 and held it in 4 quarters.
  • Thompson Davis & Co's QuidelOrtho position peaked at $11K in Q2 2017.
  • 148 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2018.

Based on Thompson Davis & Co's 13F filing for Q1 2018, filed 2 May 2018.